Lung Cancer Symposium 2024

You are invited to join the second Nordic Lung Cancer Symposium.

Join this symposium and take part in discussions with experts as they frame the challenges of lung cancer and address clinical models for risk prediction, early diagnosis and screening plans in the Nordics. International experts from the UK and USA will share up-to-date experiences from their respective countries. A panel discussion will include implementation models for selection and CT screening.

Tentative Program

​​10:00​–10:10 Welcome / Introductions
Charlotte Homme, Head of Membership & Events, Oslo Cancer Cluster (confirmed)
Ingrid Stenstadvoll Ross, CEO, Norwegian Cancer Society (Invited)
Ole Alexander Oppdahlshei (Invited)

​​10:10​–10:30
The challenges and benefits of lung cancer screening
Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway.
Lung Symposium, Chair, moderator. (Confirmed) ​​

10:30​–​11:00​
Lung Cancer Screening: Lessons from the United Kingdom
David Baldwin, MD, PhD, Professor, Nottingham University Hospital. Nottingham, UK (Confirmed) ​​

11:30​–11:50
Finland – Efforts and progress in lung cancer screening
Pending​​

11:50​–12:10
Iceland – Efforts and progress in lung cancer screening
Hronn Haroardottir, Pulmonologist, Landspitali University Hospital (Confirmed)

12:10-12:40
Lunch & Networking Session 

12:00 – 13:00
Sweden – Efforts and progress in lung cancer screening
Bengt Bergman, MD, PhD, Professor, Gothenburg University, National Working Group for Lung Cancer Care, Sweden (Confirmed)

13:00 – 13:30
Denmark – Efforts and progress in lung cancer screening, and the PLUS Project
Michael Stenger, MD, PhD, Associate Professor, PLUS Project Director, Svendborg Hospital, Odense, Denmark (Confirmed)

13:30 – 14:15
Norway – E-Lung Study, Innovative Models for Screening Selection and Smoking Cessation Progress Report and The TIDL Study.
Oluf Dimitri Røe, MD, PhD, Professor, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway (Confirmed)
Toai Duc Nguyen, MD, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU/Norwegian University of Science and Technology, Department of Oncology, Levanger Hospital, Norway (Confirmed)
Haseem Ashraf, Associate Professor, University of Oslo, Oslo, Department of Imaging, Akershus University Hospital, Oslo, Norway (Invited)

14:15 – 14:30
Coffee Break

14:30 – 15:00
Lung Cancer Screening in the United States: What Works, What Doesn’t
Florian Fintelmann, MD, Associate Professor, Massachusetts General Hospital, Boston (Digital)

15:00 – 16:00
Panel Discussion and Conclusions: This is the right time to implement lung cancer screening in Norway
Panelists, All speakers, plus stakeholders.